Chemonucleolysis or manipulation for lumbar disc herniation?

ISRCTN ISRCTN85788243
DOI https://doi.org/10.1186/ISRCTN85788243
Secondary identifying numbers ND0020 T367 Burton R&D
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
22/02/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Kim Burton
Scientific

Spinal Research Unit
30 Queen Street
Huddersfield
HD1 2SP
United Kingdom

Phone +44 (0)1484 535200
Email kim@spineresearch.org.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesThe purpose of this study is to compare the effects of two treatment modalities available for lumbar disc herniation. The principle aim of the project is to ascertain which, if either, treatment is superior in terms of reducing symptoms/disability, and the relative cost effectiveness/patient satisfaction. The treatments to be studied are chemonucleolysis and osteopathic manipulation. Despite the choice of a well defined low back pathology for this trial, it may be that some 'types' of patient respond better to one or other of the treatments; strenuous attempts will be made to identify any such categories. The benefits to the NHS will be the determination of the more cost-effective treatment for this condition. Should the result favour manipulation, there will be the potential for reduction both of therapeutic costs and of orthopaedic waiting lists.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedLumbar disc herniation
Intervention1. Chemonucleolysis
2. Osteopathic manipulation
Intervention typeOther
Primary outcome measure1. Symptoms/disability and the relative cost effectiveness/patient satisfaction.
2. Pain (back and leg) and disability
Secondary outcome measuresTherapeutic failure
Overall study start date02/01/1994
Completion date31/12/1998

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants40
Key inclusion criteriaPatients with lumbar disc herniation
Key exclusion criteriaNot provided at time of registration
Date of first enrolment02/01/1994
Date of final enrolment31/12/1998

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Spinal Research Unit
Huddersfield
HD1 2SP
United Kingdom

Sponsor information

NHS R&D Regional Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.doh.gov.uk

Funders

Funder type

Government

NHS Executive Northern and Yorkshire (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/06/2000 Yes No